We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$472M
Cap. Flow
+$292M
Cap. Flow %
7.14%
Top 10 Hldgs %
16.99%
Holding
524
New
29
Increased
201
Reduced
78
Closed
20

Top Buys

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$24.1M
2
NVDA icon
NVIDIA
NVDA
+$16.3M
3
AMAT icon
Applied Materials
AMAT
+$16.2M
4
PH icon
Parker-Hannifin
PH
+$15.5M
5
VSAT icon
Viasat
VSAT
+$15M

Top Sells

Rank Stock Value
1
ON icon
ON Semiconductor
ON
+$42.2M
2
TPR icon
Tapestry
TPR
+$11.6M
3
BLK icon
Blackrock
BLK
+$11.2M
4
ICE icon
Intercontinental Exchange
ICE
+$10.8M
5
PLUG icon
Plug Power
PLUG
+$10.5M

Sector Composition

Rank Sector Weight
1 Technology 27.85%
2 Healthcare 19.52%
3 Consumer Discretionary 15.8%
4 Industrials 10.21%
5 Financials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
401
Citigroup
C
$228B
$366K 0.01%
5,013
– –
PFE icon
402
Pfizer
PFE
$157B
$364K 0.01%
10,083
-1,000
-9% -$35.5K
KLRS
403
Kalaris Therapeutics
KLRS
$76.2M
$364K 0.01%
713
– –
TSLA icon
404
Tesla
TSLA
$1.41T
$363K 0.01%
1,704
– –
HLNE icon
405
Hamilton Lane
HLNE
$5.13B
$350K 0.01%
3,952
+741
+23% +$62.6K
AIZ icon
406
Assurant
AIZ
$14.1B
$347K 0.01%
2,400
– –
MKL icon
407
Markel Group
MKL
$22.2B
$347K 0.01%
300
– –
RNR icon
408
RenaissanceRe
RNR
$13.7B
$346K 0.01%
2,100
– –
STOK icon
409
Stoke Therapeutics
STOK
$1.82B
$341K 0.01%
9,200
– –
KROS icon
410
Keros Therapeutics
KROS
$221M
$328K 0.01%
5,700
– –
TBIO
411
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$321K 0.01%
20,000
– –
MOS icon
412
The Mosaic Company
MOS
$8.09B
$313K 0.01%
+10,000
New +$295K
ATRA icon
413
Atara Biotherapeutics
ATRA
$94.8M
$313K 0.01%
880
– –
PM icon
414
Philip Morris
PM
$303B
$305K 0.01%
3,415
– –
RDUS
415
DELISTED
Radius Health, Inc.
RDUS
$302K 0.01%
15,000
– –
ARQT icon
416
Arcutis Biotherapeutics
ARQT
$2.96B
$299K 0.01%
+11,100
New +$347K
YMAB
417
DELISTED
Y-mAbs Therapeutics
YMAB
$296K 0.01%
10,000
– –
FNV icon
418
Franco-Nevada
FNV
$50.7B
$291K 0.01%
2,340
+140
+6% +$16.9K
FICO icon
419
Fair Isaac
FICO
$21.3B
$291K 0.01%
600
– –
CNST
420
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$288K 0.01%
12,300
– –
NSTG
421
DELISTED
NanoString Technologies, Inc.
NSTG
$284K 0.01%
4,700
-8,200
-64% -$576K
AFG icon
422
American Financial Group
AFG
$11.9B
$279K 0.01%
2,400
– –
CNXT icon
423
VanEck ChiNext Innovators ETF
CNXT
$100M
$276K 0.01%
6,135
-225
-4% -$11.4K
PCVX icon
424
Vaxcyte
PCVX
$8.81B
$265K 0.01%
14,200
– –
LOOP icon
425
Loop Industries
LOOP
$22.9M
$263K 0.01%
34,011
-565,989
-94% -$5.41M
15 16
17
18 19

Similar funds

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
WI
WealthNavi Inc Shinagawa-Ku, Tokyo, Japan $12.8B AUM 19.73% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Erste Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Erste Asset Management held 524 positions worth $4.09B, up 13% from $3.61B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Erste Asset Management deployed $292M of net new capital in Q1 2021, opening 29 new positions and adding to 201 existing holdings. Its largest new stake was Parker-Hannifin: 53,700 shares worth $17M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was ON Semiconductor, an estimated $42.2M trimmed.

  • Erste Asset Management's largest Q1 2021 buy was Parker-Hannifin: 53,700 shares worth $17M.
  • Erste Asset Management added most to Sarepta Therapeutics in Q1 2021, an estimated $24.1M increase.
  • Erste Asset Management's biggest Q1 2021 reduction was ON Semiconductor, cutting an estimated $42.2M.
  • Erste Asset Management fully exited Workhorse Group in Q1 2021, selling an estimated $7.32M.
  • Erste Asset Management's ten largest holdings make up 17% of its $4.09B portfolio in Q1 2021.
  • Erste Asset Management opened 29 new positions and closed 20 in Q1 2021.
  • Erste Asset Management's portfolio value rose 13% quarter-over-quarter to $4.09B.

Based on Erste Asset Management's 13F filing for Q1 2021, filed 25 Nov 2024.